arrow
E

Eric C. T. Geijteman

erasmus medical centre cancer institute
H指数:16
被引数:680

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Decision-making regarding anticoagulant therapy in the last phase of life: In-depth interview study with healthcare professionals (the OPTIMA trial)

关于生命最后阶段抗凝治疗决策:一项对医疗专业人员的深度访谈研究(OPTIMA试验)

2025-11-260
OA
Anti-thrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: A cohort study using population-linked routinely collected data

癌症终末期患者抗血栓治疗及其相关临床结局:一项基于人口关联常规收集数据的队列研究

2025-09-010
OAAI
Quality of vitamin K antagonist treatment during the last year of life

生命最后一年维生素k拮抗剂治疗的质量

2025-05-190
OA
Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort study

抗血栓治疗的使用与癌症患者生命末期心血管结局和出血的风险: 丹麦全国性队列研究

2025-01-010
PRE
The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis
2023-10-018
OAAI
Towards optimal use of antithrombotic therapy of people with cancer at the end of life: A research protocol for the development and implementation of the SERENITY shared decision support tool
2023-08-018
OAAI